Results 191 to 200 of about 568,827 (356)

Buprenorphine in Neonatal Abstinence Syndrome. [PDF]

, 2018
Infants exposed in utero to opioids will demonstrate a withdrawal syndrome known as neonatal abstinence syndrome (NAS). Buprenorphine is a long-acting opioid with therapeutic use in medication-assisted treatment of opioid dependency in adults and ...
Kraft, Walter K.
core   +1 more source

Opioid use Disorder for Prescription Opioid Medications

Global Journal of Addiction & Rehabilitation Medicine, 2017
Why are opioid medications prescribed in large quantities and high frequency when there is little or no proven efficacy for their therapeutic value? Why are opioids the most commonly prescribed medication in the United States for the past decades when the adverse consequences continue to grow and mount?
openaire   +1 more source

Women's and Health Care Professionals' Experiences of Discontinuing Hormone Replacement Therapy (HRT): A Systematic Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background Hormone Replacement Therapy (HRT) is used to manage menopausal symptoms, particularly vasomotor symptoms (VMS). HRT prescribing rates are rising, but most women will eventually discontinue. Objectives To explore the experiences of women stopping HRT, why women restart HRT, and the HCPs advising them. Search Strategy Embase, MEDLINE,
Sarah Bunnewell, Sabrina Keating, Jo Parsons, Martha Hickey, Sarah Hillman   +4 more
wiley   +1 more source

The impact of California wildfires on patient access to prescription opioids. [PDF]

J Am Pharm Assoc (2003), 2022
Tseregounis IE, Delcher C, Stewart SL, Gasper JJ, Shev AB, Crawford A, Wintemute G, Henry SG.   +7 more
europepmc   +1 more source

Complications Following Bilateral Salpingectomy by Indication: Population‐Based Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective Assess the short‐term surgical outcomes of bilateral salpingectomy performed as a standalone procedure, focusing on complication rates by surgical indication and age group. Design Retrospective population‐based cohort. Setting British Columbia, Canada, from January 1st, 2008, to December 31st, 2022.
Alexandra Lukey, Helena Abreu do Valle, A. Fuchsia Howard, Celeste Leigh Pearce, David G. Huntsman, Janice S. Kwon, Jessica N. McAlpine, Michael R. Law, Paramdeep Kaur, Rafael Meza, Gillian E. Hanley   +10 more
wiley   +1 more source

Improving drug identification in overdose death surveillance by using clinical natural language processing models

Journal of Forensic Sciences, EarlyView.
Abstract The rising rate of drug‐related deaths in the United States, largely driven by fentanyl, requires timely and accurate surveillance. However, critical overdose data are often buried in free‐text coroner reports, leading to delays and information loss when coded into ICD (International Classification of Disease)‐10 classifications.
Arthur J. Funnell, Panayiotis Petousis, Fabrice Harel‐Canada, Ruby Romero, Alex A. T. Bui, Adam Koncsol, Hritika Chaturvedi, Chelsea Shover, David Goodman‐Meza   +8 more
wiley   +1 more source

Learning from addiction: Craving of prescription opioids in chronic pain sufferers. [PDF]

Neurosci Biobehav Rev, 2022
Strigo IA, Murphy E, Mitchell JM, Spadoni AD.   +3 more
europepmc   +1 more source

“It's such a terrible drug”: Narratives of fentanyl dealers amid the opioid overdose crisis

Criminology, EarlyView.
Abstract The fentanyl‐fueled overdose crisis is historically lethal, yet the voices of those who sell fentanyl remain understudied. While research has focused extensively on people who use drugs (PWUD), the perspectives of people who sell fentanyl (PWSF) are largely absent from academic and policy discussions. This study draws on 87 in‐depth interviews
Brittney M. Schwehr, Sandra M. Bucerius
wiley   +1 more source

Prevalence and correlates of DSM-5 opioid withdrawal syndrome in U.S. adults with non-medical use of prescription opioids: results from a national sample. [PDF]

Am J Drug Alcohol Abuse, 2023
Mannes ZL, Livne O, Knox J, Hasin DS, Kranzler HR.   +4 more
europepmc   +1 more source

Toronto's drug policy paradox: Harm reduction sites and drug police occurrences in Toronto neighborhoods (1992–2020)

Criminology, EarlyView.
Abstract Discourse around drug policy presents a stark contrast between policing and harm reduction models, sparking debates on the state's regulatory versus protective role. Canada is an ideal case to study drug policy models due to its global recognition as a leader in harm reduction alongside continued reliance on policing of drugs.
Taylor Domingos
wiley   +1 more source